Tokyo, Japan

Cang Lam

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Terumo Corporation. Active years: 2024-2025.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Cang Lam in Vascular Prosthetics

Introduction

Cang Lam is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of vascular prosthetics, holding a total of 3 patents. His work focuses on improving medical devices that enhance patient outcomes during vascular procedures.

Latest Patents

Cang Lam's latest patents include a vessel prosthesis and a stent with an innovative delivery device. The vessel prosthesis features blunted wire ends that can take on various configurations, such as end caps and curved ends. These novel ends provide a smooth surface that minimizes trauma to blood vessel walls during placement. Additionally, his stent is designed with a generally cylindrical body made from a single woven nitinol wire. The stent's ends include loops with marker members for visualizing its position, and it may also incorporate an inner flow diverting layer.

Career Highlights

Cang Lam is currently associated with Terumo Corporation, a leading company in the medical device industry. His work at Terumo has allowed him to focus on developing advanced vascular solutions that address critical needs in healthcare.

Collaborations

Cang collaborates with talented colleagues, including Shirley Vong and Priscilla Tsai. Their combined expertise contributes to the innovative projects at Terumo Corporation.

Conclusion

Cang Lam's contributions to vascular prosthetics through his patents demonstrate his commitment to advancing medical technology. His innovative designs aim to improve patient safety and efficacy in vascular procedures.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…